Why the study?
Asymptomatic severe AS poses a clinical challenge with variations in recommendations for management across contemporary guidelines.
Does early intervention reduce major adverse cardiovascular events in patients with asymptomatic severe aortic stenosis compared to clinical surveillance?
Does early intervention reduce major adverse cardiovascular events in patients with asymptomatic severe aortic stenosis compared to clinical surveillance?
Answers are grounded in this paper and cite their sources.
Early intervention in asymptomatic severe aortic stenosis reduces major adverse cardiovascular events, primarily driven by fewer unplanned hospitalizations, supporting a proactive approach in selected patients.
BACKGROUND: Asymptomatic severe aortic stenosis (AS) poses a clinical challenge with variations in recommendations for management. OBJECTIVES: We sought to compare contemporary guidelines focusing on asymptomatic AS management and present a summary of contemporary studies on early intervention in these patients. METHODS: Systematic search of electronic databases was conducted with guidelines analyzed using a comparative matrix. A pooled random-effects meta-analysis of randomized controlled trial (RCT) data comparing intervention versus clinical surveillance in asymptomatic severe AS was also performed. RESULTS: Four guidelines from ACC/AHA, ESC/EACTS, JCS/JSCS/JATS/JSVS, and NICE were included encompassing 108 recommendations. Consensus was found for intervention thresholds including left ventricular dysfunction and very severe AS while discrepancies existed in the utility of biomarkers, myocardial fibrosis, exercise stress testing and choice of intervention. Despite variation in study inclusion criteria, current RCTs on the management of asymptomatic AS indicated a significant reduction in rates of major adverse cardiovascular events when comparing early intervention to clinical surveillance (hazard ratio [HR] 0.52 [0.42, 0.63]), driven primarily by reductions in unplanned hospitalizations (HR 0.41 [0.32, 0.52]). CONCLUSION: While there is broad consensus on classic indicators of severity such as left ventricular dysfunction as indication for intervention, guidelines diverge on other high-risk features warranting intervention. Early studies indicate the overall safety of early intervention, although further work is needed to identify whether it can reduce the risk of hard clinical endpoints. This underscores the need for further research and updated guidelines to clarify the optimal thresholds for intervention and harmonize treatment pathways for the growing number of patients with asymptomatic AS.
No takes yet. Share an insight, caveat, or question.
Grbac et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: